{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:17:07Z","timestamp":1783545427147,"version":"3.55.0"},"reference-count":21,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1001\/jamacardio.2018.0398","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T16:39:53Z","timestamp":1522859993000},"page":"498","source":"Crossref","is-referenced-by-count":97,"title":["Effects of Sacubitril\/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure"],"prefix":"10.1001","volume":"3","author":[{"given":"Alvin","family":"Chandra","sequence":"first","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldrin F.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Claggett","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S.","family":"Desai","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[{"name":"Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Zile","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Swedberg","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden"},{"name":"National Heart and Lung Institute, Imperial College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Rouleau","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College, London, England"},{"name":"Institut Cardiologie de Montreal, Universit\u00e9 de Montreal, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor C.","family":"Shi","sequence":"additional","affiliation":[{"name":"Novartis, East Hanover, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Lefkowitz","sequence":"additional","affiliation":[{"name":"Novartis, East Hanover, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzvetana","family":"Katova","sequence":"additional","affiliation":[{"name":"National Hospital of Cardiology, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J. V.","family":"McMurray","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"hoi180008r1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/SPC.0b013e328340744d","article-title":"Quality of life and symptoms of depression in advanced heart failure patients and their partners.","volume":"4","author":"Jaarsma","year":"2010","journal-title":"Curr Opin Support Palliat Care"},{"issue":"3","key":"hoi180008r2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/heart.87.3.235","article-title":"Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables.","volume":"87","author":"Juenger","year":"2002","journal-title":"Heart"},{"issue":"11","key":"hoi180008r3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure.","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"hoi180008r4","doi-asserted-by":"publisher","first-page":"e003430","DOI":"10.1161\/CIRCHEARTFAILURE.116.003430","article-title":"Health-related quality of life outcomes in PARADIGM-HF.","volume":"10","author":"Lewis","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"19","key":"hoi180008r5","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.jacc.2012.06.054","article-title":"Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure.","volume":"60","author":"Veazie","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"hoi180008r6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jchf.2016.04.010","article-title":"Patient-reported outcomes in chronic heart failure: applicability for regulatory approval.","volume":"4","author":"Psotka","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"10","key":"hoi180008r7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jchf.2016.07.004","article-title":"Centering the patient in meaningful outcomes and regulatory approval.","volume":"4","author":"Lewis","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"9","key":"hoi180008r8","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/eurjhf\/hft052","article-title":"Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).","volume":"15","author":"McMurray","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"hoi180008r9","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi180008r10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/00031305.1992.10475842","article-title":"A note on the delta method.","volume":"46","author":"Oehlert","year":"1992","journal-title":"Am Stat"},{"issue":"23","key":"hoi180008r11","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1053\/euhj.2002.3255","article-title":"Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population.","volume":"23","author":"Hobbs","year":"2002","journal-title":"Eur Heart J"},{"issue":"2","key":"hoi180008r12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/(ISSN)1099-1557","article-title":"The effect of \u00df-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis.","volume":"16","author":"Dobre","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"hoi180008r13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/CIRCHEARTFAILURE.112.966861","article-title":"Still at the drawing board: improving quality of life in heart failure.","volume":"5","author":"Lewis","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"4","key":"hoi180008r14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ahj.2004.12.010","article-title":"Monitoring clinical changes in patients with heart failure: a comparison of methods.","volume":"150","author":"Spertus","year":"2005","journal-title":"Am Heart J"},{"issue":"8","key":"hoi180008r15","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIR.0b013e3182447787","article-title":"Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association.","volume":"125","author":"Levine","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"hoi180008r16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/(ISSN)1751-7117","article-title":"Sexual concerns and sexual counseling in heart failure.","volume":"24","author":"Medina","year":"2009","journal-title":"Prog Cardiovasc Nurs"},{"issue":"1","key":"hoi180008r17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10557-011-6284-x","article-title":"Evaluation of the functional status questionnaire in heart failure: a sub-study of the second cardiac insufficiency bisoprolol survival study (CIBIS-II).","volume":"25","author":"Gallanagh","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"hoi180008r18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1476-5381.2010.00691.x","article-title":"UK-414,495, a selective inhibitor of neutral endopeptidase, potentiates pelvic nerve-stimulated increases in female genital blood flow in the anaesthetized rabbit.","volume":"160","author":"Wayman","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"1","key":"hoi180008r19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bmc.2006.10.002","article-title":"Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder.","volume":"15","author":"Pryde","year":"2007","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"hoi180008r20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.114.013748","article-title":"Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.","volume":"131","author":"Packer","year":"2015","journal-title":"Circulation"},{"issue":"14","key":"hoi180008r21","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/jama.2009.457","article-title":"Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial.","volume":"301","author":"Flynn","year":"2009","journal-title":"JAMA"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2677630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T18:54:11Z","timestamp":1720205651000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2018.0398"}},"subtitle":["A Secondary Analysis of the PARADIGM-HF Trial"],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2018.0398","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}